Champions Oncology Inc Strategic Asset Allocation Index
Champions Oncology Inc strategic asset allocation index. Champions Oncology Inc (CSBR) has a Strategic Asset Allocation Index of 760.1% as of July 2023. Strategic assets (PP&E of $14.46 Million plus long-term investments of $-) total $14.46 Million, measured against net assets of $1.90 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See Champions Oncology Inc balance sheet independence to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of Champions Oncology Inc (2000–2023)
Strategic asset allocation index of Champions Oncology Inc from 2000 to 2023. This chart shows how Champions Oncology Inc's Strategic Asset Allocation Index has evolved across 15 annual periods from 2000 to 2023. As of July 2023, the index stands at 760.1%, representing strategic assets of $14.46 Million against net assets of $1.90 Million USD. Check CSBR intangible-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Champions Oncology Inc Strategic Asset Allocation Index by Year (2000–2023)
Champions Oncology Inc strategic asset allocation index by year from 2000 to 2023. The table below presents the year-by-year Strategic Asset Allocation Index for Champions Oncology Inc from 2000 to 2023, covering 15 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see Champions Oncology Inc (CSBR) market capitalisation.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2023 | 312.9% | $14.50 Million | $14.50 Million | $- | $4.64 Million | ▲ +143.9 pp |
| 2022 | 168.9% | $15.36 Million | $15.36 Million | $- | $9.10 Million | ▼ -27.8 pp |
| 2021 | 196.7% | $14.61 Million | $14.61 Million | $- | $7.43 Million | ▲ +63.5 pp |
| 2020 | 133.2% | $6.79 Million | $6.79 Million | $- | $5.10 Million | ▲ +19.4 pp |
| 2019 | 113.8% | $2.55 Million | $2.55 Million | $- | $2.24 Million | ▼ -190.2 pp |
| 2017 | 304.0% | $1.22 Million | $1.22 Million | $- | $400.00K | ▲ +44.3 pp |
| 2016 | 259.7% | $618.00K | $618.00K | $- | $238.00K | ▲ +254.1 pp |
| 2015 | 5.6% | $452.00K | $452.00K | $- | $8.06 Million | ▼ -8.0 pp |
| 2014 | 13.6% | $434.00K | $434.00K | $- | $3.20 Million | ▲ +8.1 pp |
| 2013 | 5.4% | $414.00K | $414.00K | $- | $7.60 Million | ▼ -763.0 pp |
| 2011 | 768.4% | $146.00K | $146.00K | $- | $19.00K | ▲ +761.8 pp |
| 2010 | 6.7% | $105.00K | $105.00K | $- | $1.58 Million | ▲ +2.4 pp |
| 2009 | 4.2% | $81.00K | $81.00K | $- | $1.92 Million | ▼ -207.6 pp |
| 2001 | 211.8% | $320.00K | $320.00K | $- | $151.06K | ▲ +173.5 pp |
| 2000 | 38.4% | $342.00K | $342.00K | $- | $891.69K | — |